申请人:ROSWELL PARK CANCER INSTITUTE
公开号:US20150051245A1
公开(公告)日:2015-02-19
The invention relates to protein binding inhibitor compounds and methods of identifying and using them. The invention further relates to pharmaceutical compositions and methods for treating cell proliferative disorders, especially cancer.